Low-grade inflammation has been observed in subjects with T2DM, along with the increase in systemic plasma proinflammatory and inflammatory cytokines such as TNF-α, IL-6, etc. NF-κB, a transcriptional factor, is involved in the activation of many genes linked to inflammation [24]. The gene discussed is IL6; the disease is type 2 diabetes mellitus.